23643-36-9
23643-36-9 structure
- Name: 2',3',5'-Tri-O-benzoyl-2'-C-methyluridine
- Chemical Name: 1-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)uracil
- CAS Number: 23643-36-9
- Molecular Formula: C31H26N2O9
- Molecular Weight: 570.55
- Catalog: Signaling Pathways Cell Cycle/DNA Damage Nucleoside Antimetabolite/Analog
- Create Date: 2016-06-20 13:03:02
- Modify Date: 2025-09-01 18:49:23
-
1-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1].
| Name | 1-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)uracil |
|---|---|
| Synonyms |
2',3',5'-Tri-O-benzoyl-2'-C-methyluridine
Uridine, 2'-C-methyl-, 2',3',5'-tribenzoate 2'-C-Methyl-,2',3',5'-tribenzoateuridine 2'-C-METHYL-, 2',3',5'-TRIBENZOATEURIDINE |
| Description | 1-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione is a uridine analog. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C31H26N2O9 |
| Molecular Weight | 570.55 |
| Exact Mass | 570.163818 |
| PSA | 142.99000 |
| LogP | 6.51 |
| Index of Refraction | 1.657 |
|
~%
23643-36-9 |
| Literature: Harry-O'kuru, Rogers E.; Kryjak, Emily A.; Wolfe, Michael S. Nucleosides and Nucleotides, 1997 , vol. 16, # 7-9 p. 1457 - 1460 |
|
~%
23643-36-9 |
| Literature: Harry-O'kuru, Rogers E.; Kryjak, Emily A.; Wolfe, Michael S. Nucleosides and Nucleotides, 1997 , vol. 16, # 7-9 p. 1457 - 1460 |
| Precursor 2 | |
|---|---|
| DownStream 3 | |
